Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology

 Amgen (NASDAQ: AMGN) and AstraZeneca (AZN), with its biologics research and development arm MedImmune, today announced the upcoming...

Simposio destinado a resaltar la aplicación práctica de nuevos biomarcadores para el daño renal agudo

-- Astute Medical patrocina el simposio en el congreso europeo de medicina intensiva (ESICM) Un grupo internacional de intensivistas...

Simposio per evidenziare l'utilizzo pratico del nuovo test dei biomarcatori per grave insufficienza renale

-- Astute Medical patrocina il simposio presso la Conferenza annuale europea di terapia intensiva  Un gruppo di esperti internazionali di...

Symposium visant à mettre en avant l'utilisation pratique d'un nouveau dosage des biomarqueurs dans le diagnostic de l'insuffisance rénale aiguë

-- Astute Medical sponsorise un symposium lors du congrès annuel de la société européenne de soins intensifs. Lors d'un...

KLOX Technologies gibt Genehmigung seiner innovativen Behandlung gegen Acne vulgaris in Kanada bekannt

Das Unternehmen beantragte auch die CE-Kennzeichnung in Europa Lumigel Cleanse System ist sicher, wirksam und im Begriff, die Situation für...

IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum

 Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that Dr. Daniel G. Teper, Company Chairman and...

New England Biolabs Intends to Appeal Court Decision in Lawsuit over Theft of its Trade Secrets

New England Biolabs, Inc. (NEB®), which filed suit against Enzymatics and three former NEB employees for stealing its intellectual property,...

Nektar to Host Investor and Analyst R&D Day in New York City

 Nektar Therapeutics (Nasdaq: NKTR) will host an Investor and Analyst R&D Day for its institutional investors and research analysts on...

Weight Loss Surgery from Beverly Hills Physicians can Change Lives

The network of health, wellness and beauty specialists at Beverly Hills Physicians have garnered a great deal of acclaim for their success in...

Severely Obese Benefit from Multifaceted Approach to Weight Loss, Says Dr. Feiz

While the latest and supposedly greatest diet fads flood the market, promising quick and easy results, Michael Feiz, M.D., F.A.C.S.,...

Stop Unnecessary Suffering by Detecting Common Indoor Allergens with PRO-LAB's® NEW Allergen Test Kit

Tired of constant headaches? Sneezing? How about itchy eyes? Millions of Americas answer "yes" to these questions because they suffer from...

Inova to Bring Healthplex to Akridge and Soave Enterprises' Loudoun Parkway Center

 Akridge and Soave Enterprises have sold 8.7 acres of their 137-acre land holdings known as Loudoun Parkway Center, which is located on the...

Eisais Zonegran® (Zonisamid) für Kinder mit fokalen Anfällen in Deutschland und Österreich zugelassen

 Neue Behandlungsoption für pädiatrische Patienten nach Indikationserweiterung durch EU-Kommission...

Eisais Zonisamid für Kinder mit fokalen Anfällen in Deutschland und Österreich zugelassen

Neue Behandlungsoption für pädiatrische Patienten nach Indikationserweiterung durch EU-Kommission verfügbar Zonisamid steht jetzt...

Eisai's Zonegran® (zonisamide) geregistreerd voor gebruik bij kinderen met partiële epilepsie in het VK en Nederland

 Nieuwe pediatrische epilepsiebehandeling beschikbaar na registratie-uitbreiding door de Europese Commissie Zonegran® (zonisamide)...

La Commissione Europea approva l'indicazione per l'uso di Zonegran® (zonisamide) nei bambini con epilessia parziale

COMUNICATO STAMPA SOLO PER I MEDIA EUROPEI NON PER I MEDIA STATUNITENSI La commissione europea (EC) ha approvato l'aggiornamento pediatrico della...

La Commission Européenne donne son feu vert a l'extension des indications de Zonegran® (zonisamide) chez les enfants atteints de crises d'épilepsie partielles

COMMUNIQUÉ DE PRESSE À L'ATTENTION EXCLUSIVE DES MÉDIAS EUROPÉENS, NE S'ADRESSE PAS AUX MÉDIAS DES ÉTATS-UNIS La...

La Comisión Europea aprueba la ampliación en la indicación de Zonegran® (zonisamida) para su uso en niños con epilepsia parcial

PUBLICACIÓN DE PRENSA ÚNICAMENTE PARA UE NO PARA MEDIOS EE.UU. La Comisión Europea (CE) ha aprobado la ampliación en la...

ScriptPro Certified with Appriss NPLEx

ScriptPro announces that its SP Central Pharmacy Management System Point of Sale now interfaces with the Appriss NPLEx (National Precursor Log...

benefitalign® Goes Live in Three Major U.S. Markets

 As the U.S. Congress spins its wheels on the Affordable Care Act, benefitalign®, a revolutionary technology company connecting consumers...